Illumina
ILMN
564 hedge funds and large institutions have $23.8B invested in Illumina in 2017 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 206 increasing their positions, 181 reducing their positions, and 42 closing their positions.
88% more first-time investments, than exits
New positions opened: 79 | Existing positions closed: 42
14% more repeat investments, than reductions
Existing positions increased: 206 | Existing positions reduced: 181
6% more funds holding
Funds holding: 530 → 564 (+34)
1% more capital invested
Capital invested by funds: $23.6B → $23.8B (+$285M)
0.15% less ownership
Funds ownership: 97% → 96.85% (-0.15%)
14% less call options, than puts
Call options by funds: $158M | Put options by funds: $183M
25% less funds holding in top 10
Funds holding in top 10: 12 → 9 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$217M |
| 2 |
Cerity Partners
New York
|
+$133M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$120M |
| 4 |
FAM
Fred Alger Management
New York
|
+$97.5M |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
+$93.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$549M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$168M |
| 3 |
JP Morgan Chase
New York
|
-$163M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$158M |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
-$131M |
ILMN Hedge Fund Activity: Q2 2017 in Review
564 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Illumina (ILMN) for Q2 2017, worth a combined $23.8B — up 1.2% from $23.6B a quarter earlier.
Buyers outnumbered sellers: 79 funds opened new ILMN positions and 42 closed out — a net gain of 37 holders — while 206 added to existing stakes and 181 trimmed.
The largest buyer was Winslow Capital Management, opening a new position worth an estimated $217M. The largest seller was T. Rowe Price Associates, cutting an estimated $549M.
- 564 institutional investors held Illumina (ILMN) as of Q2 2017, up from 530 in Q1 2017.
- Funds reported $23.8B of Illumina stock for Q2 2017, up 1.2% quarter-over-quarter.
- 79 funds opened new Illumina positions in Q2 2017 and 42 closed out, a net change of +37 holders.
- The largest Illumina buyer in Q2 2017 was Winslow Capital Management, an estimated $217M added.
- The largest Illumina seller in Q2 2017 was T. Rowe Price Associates, an estimated $549M sold.
Based on aggregated 13F filings for Q2 2017.